RE: Avacta/Deepverge9 Nov 2021 10:08
Interesting how Saliva testing is still alive and kicking with DV...
Diagnostics has always been about taking samples and testing and hoping finds something or in the case of your GP a best guess based on symptoms but as we know many diseases/viruses don't manifest symptoms...so the move now is to digitalize diagnostics. A simple test that can be administered to pick up one or more diseases/viruses which may be present but not easily or quickly detected using current methods....
Companies like DV and their partners are in this space and one of their 'key' partners is Avacta. We have new tech going into new tech...NO WONDER IT'S TAKING TIME...
'And the Aptamar Group, and we have worked and still do continue to work with Avacta, the Aptamar group have been instrumental in helping us to expand quite rapidly,'
https://youtu.be/liNlfzVKZlw
17 March 2021
'In addition, under the clinical trial supervision of the Royal College of Surgeons, Ireland, 40 subjects, 16 of
which were independently confirmed as COVID19 positive with PCR tests, provided breath samples that were
tested on the Microtox® BT nano-optofluidic chip surface with Affimer® reagents (“Avacta Group”)iv and
Optimers (“Aptamer Group”) together the (“Binding Agents”)
https://www.rns-pdf.londonstockexchange.com/rns/6108S_1-2021-3-17.pdf